07/29 Taiwan BIO Weekly
2025-07-29 |
| Taiwan BIO Weekly |
| Elixiron Immunotherapeutics' new drug EI-1071 gains international recognition 28 July, 2025 Determined not to let foreign pharmaceutical companies dominate the field, Elixiron Immunotherapeutics is focusing on modulating brain immunity as its core strategy. The company is developing a microglia-targeting drug, Enrupatinib (EI-1071), primarily for the treatment of Alzheimer's disease. This novel therapy has been recognized by the Global Neurodegeneration Proteomics Consortium, founded by Bill Gates, and has already entered Phase II clinical trials. More... (in Chinese) |
| APN LifeSciences develops APN-1607 as a breakthrough early detection tool 28 July, 2025 Taiwanese pharmaceutical companies are quickly catching up in the race to develop diagnostics and treatments for dementia. Among them, APN LifeSciences, which focuses on precision diagnostics for neurodegenerative diseases, has received strategic investment from the Alzheimer's Drug Discovery Foundation (ADDF), founded by the Estee Lauder family. The company's PET imaging tracer, 18F-APN-1607 (Florzolotau [18FJ]), enables real-time tracking of tau protein pathology in the brain, allowing accurate diagnosis of Alzheimer's disease and progressive supranuclear palsy (PSP)--both tau-related disorders. The product has already been used in over 4,000 cases globally, building a large-scale clinical imaging database and supporting global multi-center clinical trials, including: A Phase II trial for Alzheimer's disease in the US, and A Phase III diagnostic trial for PSP, which has received Orphan Drug and Fast Track Designations from the US FDA. More... (in Chinese) |
| BIO Asia-Taiwan Forum Paves Way for Japan-Taiwan Synergy in AI, Oncology, and Regenerative Medicine 28 July, 2025 The 2025 BIO Asia-Taiwan Japan Regional Cooperation Forum concluded successfully in Taipei on July 24th, fostering a dynamic exchange between leaders in the Japanese and Taiwanese biotechnology sectors. Co-hosted by the Japan Bioindustry Association (JBA), Taiwan's Biotechnology and Pharmaceutical Industries Promotion Office, and the Taiwan Bio Industry Organization, the event provided a key platform to explore Japan's biotech ecosystem and discuss future partnership opportunities. More... |
| Europe, US, and Asia: 10 Countries Feature at BIO AsiaŠTaiwan 2025 Regional Collaboration Forums 26 July May, 2025 In collaboration with the Taiwan External Trade Development Council (TAITRA), BIO AsiaŠTaiwan 2025 again hosted the Regional Collaboration Forums, bringing together representatives from ten countries across Europe, the US, and Asia, including Australia, South Korea, the United States, Japan, the Netherlands, the Philippines, Canada, India, and Singapore. Also represented was the International Council of Biotechnology Associations. More... |
| Taiwan Bio-Manufacturing Company to mass produce vaccines 25 July, 2025 Taiwan Bio-Manufacturing Company said Friday its vaccine facility in Zhubei, Hsinchu County will go online next year. TBMC CEO Chang Yu-hsiang announced that plant construction will finish by year-end, with verification in Q1 2026 and full-scale production in Q2, per CNA. The plant will produce 13 million doses annually, with the ability to quadruple output in emergencies, he said at BIO Asia-Taiwan in Taipei. More... |
| Taiwan Boosts Semiconductor Innovation in Biomedicine 25 July, 2025 Taiwan's National Science and Technology Council (NSTC) has unveiled a strategic roadmap to propel the nation's semiconductor sector into new frontiers, focusing on four key strategies: sustaining current advantages, global expansion, innovation in applications, and adaptation for sustainability. The goal is to solidify Taiwan's leadership in the global semiconductor industry while expanding into vital sectors like biomedicine and agriculture. More... |
| BIO Asia-Taiwan 2025 Highlights from the Innovation Forum and Special Sessions 25 July, 2025 The 2025 BIO Asia-Taiwan 2025 Conference entered its third day on Friday, with the Innovation Forum continuing its focus on novel antibody therapies, while Special Sessions zeroed in on key topics such as smart healthcare, precision health, digital health, and Alzheimer's Disease. More... |
| BIO Asia-Taiwan 2025 Exhibition Opens! 24 July, 2025 The BIO Asia-Taiwan 2025 Exhibition opened its doors today at the Taipei Nangang Exhibition Center, TaiNEX 1. With this year's exhibition bigger than ever with 2,200 booths, BIO Partnering also registered a record 8,800 meetings scheduled. During today's official opening ceremony, two major honors were also presented: the 2025 BIO Asia Award and the 2025 Taiwan BIO Awards, recognizing excellence in this industry. More... |
| Next Wave of Biotech Opportunities! BIO Asia-Taiwan 2025 Opens 23 July, 2025 The BIO Asia-Taiwan 2025 convention officially kicked off today at Taipei Nangang Exhibition Center, TaiNEX 1 and 2. This year's three-day conference program features three major forums: the Innovation Forum, the Investment Summit, and the Regional Collaboration Forums. Opening remarks were delivered by Johnsee Lee, Chairman of BIO Asia-Taiwan; Liu Lee-Cheng, Chairman of the Taiwan Bio Industry Association (Taiwan BIO); and Kelly Seagraves, Vice President of National Security and International Affairs at the US-based Biotechnology Innovation Organization (BIO). More... |
| Australia Takes Centre Stage at BIO Asia-Taiwan 2025 with Robust Clinical Trials and Health Innovation Showcase 24 July, 2025 Australia has officially launched its presence at BIO Asia-Taiwan 2025, with a dynamic delegation of 26 leading life sciences organisations spearheaded by the Australian Trade and Investment Commission (Austrade). Running from 23-25 July, the live event brings together global biotech trailblazers, with Australia firmly in the spotlight as a trusted partner in clinical development and health innovation. More... |
| Bora Health partners with Dr. Reddy's Labs to address unmet medical needs in Taiwan 24 July, 2025 Bora Health, subsidiary of SunWay Biotech which focuses on pharmaceutical distribution and sales in Taiwan, has entered into a strategic collaboration with global pharmaceutical leader Dr. Reddy's Laboratories. The partnership grants Bora Health the distribution rights in Taiwan of 4 products in the infection, central nervous system therapeutic areas and rare diseases. More... |
| Ex-Academia Sinica head, Filipino entrepreneur to receive BIO Asia Award 21 July, 2025 Former Academia Sinica President Wong Chi-huey and Philippine infectious disease specialist and entrepreneur Raul V. Destura were named recipients of the 2025 BIO Asia Award on Monday, according to the BIO AsiaŠTaiwan international committee. More... |
| ========================================= |
| Taiwan Bio Industry Organization (Taiwan BIO) Contact: Daisy Tsai Tel: +886 2 27836028 ext 14 FAX : +886 2 27836027 Mobile: +886 933-139647 | Line ID : daisy222 Email: daisy@taiwanbio.org.tw BIO Asia-Taiwan 2025 (23-27 July, 2025) ========================================= Taiwan Bio Industry Organization (Taiwan BIO) Room C229, Bldg. C, No.99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei, Taiwan (11571) ========================================= |